PositoAI/ CA/ Eupraxia Pharmaceuticals Inc.

Eupraxia Pharmaceuticals Inc.

Toronto: EPRX · Healthcare

Positivity Index

#10,176 / 12,643

Global

#1,152 / 1,768

Canada

Positivity Score

18,106

Rank→

Overview Go Deep Penta Pattern Funda News For this company Histo

PosiRed: no active red flags

Eupraxia Pharmaceuticals Inc. — Overview & Financial Snapshot

Eupraxia Pharmaceuticals Inc. (Toronto: EPRX) is a Healthcare company, ranked #10,176 of 12,643 companies globally and #1,152 of 1,768 in Canada on PositoAI, with a Positivity Score of 18,106. Its market capitalisation is ₹4,481.30 Cr (C$659.41M), P/E ratio is -7.1 and P/B ratio is 3.58. It has no active red flags (PosiRed) or yellow flags (PosiYellow) on record.

For financial statements, ratio trends and score history, Go Deep →

Top-ranked Healthcare companies

#21 Organigram Global Inc. 25,113 #25 Quest PharmaTech Inc. 24,859 #45 Vaxil Bio Ltd. 24,515 #89 Cipher Pharmaceuticals Inc. 23,939 #138 CanadaBis Capital Inc 23,370

— Nothing to show —

OpenAI is reading recent news...

Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need. Its proprietary Diffusphere technology optimizes drug delivery for applications with significant unmet medical need. The company's product portfolio includes EP-104IAR, which is in Phase III clinical trial for the treatment of knee osteoarthritis; EP-104GI that is in Phase II clinical trial for treating eosinophilic esophagitis; and EP-104, which is under preclinical studies for the treatment of gastrointestinal tract, such as eosinophilic esophagitis. The company was formerly known as Plaza Capital Partners Inc. and changed its name to Eupraxia Pharmaceuticals Inc. in May 2012. Eupraxia Pharmaceuticals Inc. was incorporated in 2011 and is headquartered in Victoria, Canada.

P/B Ratio 3.58

P/E Ratio -7.1

D/E Ratio 0.01

ROE -66.70%

Owes vs Owns ? —Not available

Dividend Yield 0.00%

Trailing EPS ₹-95.82C$-1.41

Forward EPS ₹-99.59C$-1.47

Beta 1.22

Market Cap ₹4,481.30 CrC$659.41M

What these numbers mean →

What does Eupraxia Pharmaceuticals Inc. do?

What is Eupraxia Pharmaceuticals Inc.'s P/E and P/B ratio?

Eupraxia Pharmaceuticals Inc. has a P/E ratio of -7.1 and a P/B ratio of 3.58.

What is Eupraxia Pharmaceuticals Inc.'s debt-to-equity ratio?

Eupraxia Pharmaceuticals Inc. has a debt-to-equity ratio of 0.01.

What is Eupraxia Pharmaceuticals Inc.'s Positivity rank?

Eupraxia Pharmaceuticals Inc. is ranked #10,176 of 12,643 companies globally and #1,152 of 1,768 in Canada on PositoAI, with a Positivity Score of 18,106.

Does Eupraxia Pharmaceuticals Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?

No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Eupraxia Pharmaceuticals Inc..

Where can I read the latest news about Eupraxia Pharmaceuticals Inc.?

Recent headlines about Eupraxia Pharmaceuticals Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.

Does Eupraxia Pharmaceuticals Inc. have a PositoAI PosiShot or QR code?

Yes. A dated PosiShot of Eupraxia Pharmaceuticals Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.

0 / 1000

🔒 Private — stored only in this browser, never sent to PositoAI. Clear anytime in Settings.